NCT00041600

Brief Summary

The purpose of this study is to identify genes responsible for epilepsy, brain malformations and disorders of human cognition.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,500

participants targeted

Target at P75+ for all trials

Timeline
50mo left

Started Apr 1996

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Apr 1996Jun 2030

Study Start

First participant enrolled

April 1, 1996

Completed
6.3 years until next milestone

First Submitted

Initial submission to the registry

July 11, 2002

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 12, 2002

Completed
27.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2030

Last Updated

September 21, 2023

Status Verified

September 1, 2023

Enrollment Period

34.2 years

First QC Date

July 11, 2002

Last Update Submit

September 20, 2023

Conditions

Keywords

epilepsyseizuresdisorders of human cognitionneuronal migrationneuronal migration disorderslissencephalyschizencephalypolymicrogyriaheterotopiamicrocephalypachygyria

Outcome Measures

Primary Outcomes (1)

  • Identification and characterization of genes important in normal brain development and associated with brain malformations.

    Genetic variants associated with disorder of brain development

    Ongoing

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will be selected through collaborations with clinicians.

You may qualify if:

  • Males and females of any age.
  • Persons with a brain malformation or disorder of cognition (familial intellectual disability \[previously known as mental retardation\] or autism).

You may not qualify if:

  • Persons without a brain malformation or disorder of cognition (familial intellectual disability (previously known as mental retardation\] or autism).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston Children's Hospital, Walsh Laboratory

Boston, Massachusetts, 02115, United States

RECRUITING

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

whole blood, DNA

MeSH Terms

Conditions

Malformations of Cortical Development, Group IICognition DisordersEpilepsySeizuresLissencephalySchizencephalyPolymicrogyriaChoristomaMicrocephaly

Condition Hierarchy (Ancestors)

Malformations of Cortical DevelopmentNervous System MalformationsNervous System DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNeurocognitive DisordersMental DisordersBrain DiseasesCentral Nervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMalformations of Cortical Development, Group IIIPathological Conditions, AnatomicalCraniofacial AbnormalitiesMusculoskeletal AbnormalitiesMusculoskeletal DiseasesMalformations of Cortical Development, Group I

Study Officials

  • Christopher A. Walsh, M.D., Ph.D.

    Harvard Institutes of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Abbe Lai, MS

CONTACT

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

July 11, 2002

First Posted

July 12, 2002

Study Start

April 1, 1996

Primary Completion (Estimated)

June 1, 2030

Study Completion (Estimated)

June 1, 2030

Last Updated

September 21, 2023

Record last verified: 2023-09

Locations